Role Supports Synergy’s Expanding Presence in Mexico, Including Initial Product Shipments to Costco MexicoWESTBROOK, Maine, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced that Pedro Colmenares has been appointed Director of Sales & Marketing for Mexico & Latin America. In this role, Mr. Colmenares will lead commercial strategy, market expansion, and go-to-market execution across the region. Mr. ...

WESTBROOK, Maine, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced new Direct Store Delivery (DSD) partnerships with Pine State Beverage, Fuhrer Beverage Company, and Banko Beverage Co. The agreements expand retail distribution of the Company’s FOCUSfactor Focus + Energy Ready-to-Drink (RTD) functional beverages and Focus + Energy brain-health shots across Maine and Pennsylvania. Consistent with S ...

WESTBROOK, Maine, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced the addition of five new Direct Store Delivery (DSD) partners, expanding retail distribution of its FOCUSfactor Focus + Energy Ready-to-Drink (RTD) functional beverages across Alaska, New York, Wisconsin, Virginia and Pennsylvania. With these new partnerships, Synergy has now established DSD coverage in ten of 50 U.S. states, repre ...

Financial Data and Key Metrics Changes - For Q3 2025, net revenue was $8 million, an increase of 12.4% from $7.1 million in the same quarter last year [11] - Gross margin improved to 70.9% from 67.2% year-over-year, driven by a favorable product mix [11] - Operating expenses rose to $4.4 million from $3.7 million, attributed to costs associated with being a public company and launching the beverage division [11] - Income from operations increased by 21.8% to $1.28 million compared to $1.05 million in Q3 2024 [11] - Net income decreased to $125,300 from $783,600 in the prior year [11] - Earnings per share fell to $0.01 from $0.11, while adjusted EBITDA per share decreased to $0.15 from $0.18 [12] Business Line Data and Key Metrics Changes - Beverage revenue for Q3 was $159,000, indicating early-stage growth in this segment [16] - The supplement business saw a price increase of 11% for Costco, with gross margins around 75% [17] Market Data and Key Metrics Changes - The company secured major distribution agreements, including with EG America and Wakefern Food Group, expanding its retail presence significantly [6][9] - New partnerships with AlaBev and Atlantic Importing Company will enhance distribution in the Southeast and New England regions [6] Company Strategy and Development Direction - The company is focused on expanding its beverage and supplement categories, leveraging new leadership and distribution partnerships [5][10] - A public offering raised $4.4 million to support retail rollouts and inventory build-up, enhancing operational flexibility [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's positioning for growth through 2025 and into 2026, citing strong execution and new retail authorizations [10][24] - The company is actively expanding its direct-to-store distribution network to capitalize on market opportunities [20] Other Important Information - The company has over 3 million cans of drink inventory available, with ongoing production to meet demand [24] - Management highlighted the importance of adding key employees to build out the sales network [24] Q&A Session Summary Question: Contribution from beverages in the quarter - Beverage revenue for Q3 was $159,000 [16] Question: Dynamics of product mix and highest margin revenue source - The supplement business saw an 11% price increase, with gross margins around 75% [17] Question: Expectations for G&A expenses moving forward - G&A expenses may increase due to new executive additions and expansion of the DSD distribution network [19]

Financial Performance - For the three months ended September 30, 2025, the company reported revenue of $8,010,112, an increase from $7,126,333 for the same period in 2024, representing a growth of approximately 12.4%[164]. - Gross profit for the three months ended September 30, 2025, was $5,680,816, or 71% of revenue, compared to $4,790,432, or 67% of revenue in 2024, marking an increase of $890,384, or 19%[168]. - Net income for the three months ended September 30, 2025, was $125,327, a decrease from $783,593 in 2024, attributed to higher expenses and other income in 2024[173]. - For the nine months ended September 30, 2025, total revenue was $24,315,642, a decrease from $24,563,039 in 2024, with Nutraceuticals revenue declining due to a new product sell-in that did not repeat[175]. - EBITDA for the three months ended September 30, 2025, was $1,311,570, compared to $1,329,334 in 2024, reflecting a slight decrease[162]. - For the nine months ended September 30, 2025, net income was $2,474,827, an increase from $2,019,309 in 2024, primarily due to a gain on loan settlements[182]. Expenses and Cash Flow - Operating expenses for the three months ended September 30, 2025, included selling and marketing expenses of $2,729,767, up from $2,509,440 in 2024, indicating an immaterial increase[169]. - The cost of revenue for the three months ended September 30, 2025, was $2,329,296, slightly down from $2,335,901 in 2024, due to a favorable product mix[167]. - Interest expense for the three months ended September 30, 2025, was $1,164,402, an increase from $705,088 in 2024, primarily due to new loan advances[172]. - For the nine months ended September 30, 2025, net cash used in operating activities was $3,209,149, compared to $1,377,479 for the same period in 2024, indicating a significant increase in cash outflow[185][186]. - Net cash provided by financing activities for the nine months ended September 30, 2025, was $3,515,856, a substantial increase from $895,972 in 2024, primarily due to new loans[187]. - Proceeds from issuing common stock amounted to $3,880,462 for the nine months ended September 30, 2025, while there were no proceeds from common stock issuance in 2024[188]. Strategic Plans and Market Position - The company plans to grow its current product lines and expand into new markets, specifically focusing on increased distribution for the recently launched ready-to-drink beverage under the FOCUSfactor brand[189]. - The company intends to pursue additional strategic acquisitions to enhance its brand portfolio and is actively evaluating potential opportunities[189]. Other Financial Information - As of September 30, 2025, the company had cash on hand of $1,006,489 and restricted cash of $100,000 held for credit card collateral[183]. - There were no off-balance sheet arrangements during the nine months ended September 30, 2025, or the year ended December 31, 2024[190]. - The effect of inflation on operating results was not significant for the nine months ended September 30, 2025, or 2024[191]. - Critical accounting estimates include those related to revenue recognition and accounts receivable allowances, which are significant for understanding the company's financial results[192].

Exhibit 99.1 Synergy CHC Corp. Reports Third Quarter 2025 Financial Results and its Eleventh Consecutive Quarter of Profitability Third Quarter 2025 Financial Results Revenue in the third quarter of 2025 was $8.0 million, up 12.4% compared to $7.1 million in the third quarter of 2024. WESTBROOK, Maine, November 13, 2025 – Synergy CHC Corp. (NASDAQ: SNYR) ("Synergy" or the "Company"), a leading consumer health and wellness company, is announcing its financial results for the three months ended September 30, ...

WESTBROOK, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, is announcing its financial results for the three months ended September 30, 2025. “We are pleased to report our 11th quarter of profitability and double-digit revenue growth, accompanied by over 300 basis points of gross margin expansion,” said Jack Ross, CEO of Synergy CHC Corp. “We made meaningful progress across our strategic priorities by exp ...

Core Insights - Synergy CHC Corp. has announced a strategic distribution partnership with C&M Sales to enhance the availability of its FOCUSfactor® Focus + Energy products in Arkansas, capitalizing on the growing functional beverage market [1][4]. Company Overview - Synergy CHC Corp. specializes in consumer health and wellness products, with flagship brands including FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line with a 25-year legacy, distributed in the U.S., Canada, and the U.K. through major retailers [5]. - Flat Tummy focuses on women's wellness and weight management, complementing Synergy's product portfolio [5]. Partnership Details - C&M Sales, a well-established beverage distributor in Arkansas with nearly 90 years of experience, will serve as Synergy's new Direct Store Delivery partner. The company has a strong reputation for brand-building and services over 3,500 accounts statewide [2][3]. - The partnership aims to leverage C&M Sales' long-standing relationships and expertise to expand FOCUSfactor's market presence in the functional beverage category [4]. Market Position - The non-alcohol division of C&M Sales, established in 2019, has quickly become a preferred distributor for non-alcoholic beverages in Arkansas, representing over 20 leading brands [3][6]. - The collaboration is expected to enhance the visibility and availability of FOCUSfactor products, driving innovation and consumer demand in the functional beverage sector [4].

Core Insights - Synergy CHC Corp. plans to release its financial results for Q3 2025 on November 13, 2025, before market trading [1] - A conference call will be held on the same day at 9:00 a.m. ET, featuring the CEO and CFO, with a live webcast available [2] Company Overview - Synergy CHC Corp. specializes in developing and marketing consumer health and wellness products, with flagship brands including FOCUSfactor and Flat Tummy [3] - FOCUSfactor is a clinically studied brain health supplement with a 25-year legacy, distributed in major retailers across the U.S., Canada, and the U.K., and is experiencing growth in new markets [3] - Flat Tummy is a lifestyle brand focused on women's wellness and weight management, complementing Synergy's product portfolio [3]

Core Insights - FOCUSfactor has been recognized as the 1 Pharmacist Recommended OTC Memory Supplement for 2025-2026 according to the Pharmacy Times survey [1][2][3] - This recognition highlights the brand's commitment to brain-health science and consumer trust, reflecting the confidence pharmacists have in FOCUSfactor [3] Company Overview - Synergy CHC Corp. develops and markets consumer health and wellness products, with FOCUSfactor being a flagship brand known for clinically-studied formulations aimed at improving memory, focus, and cognitive clarity [3][5] - FOCUSfactor has over 20 years of category leadership and established distribution in the U.S., Canada, and the U.K. through major retailers such as Costco, Walmart, Amazon, BJ's, and Walgreens [5] - The brand is focused on expanding its brain-health and functional-wellness offerings across various channels, including pharmacy, mass retail, e-commerce, and international markets [3][5] Industry Context - Pharmacy Times serves as a leading resource for pharmacy professionals, providing insights and identifying trusted brands in key consumer health categories through its annual survey [6]